From December 23, 2020 through December 31, 2020, the OIG issued several advisory opinions. The advisory opinions analyzed (1) a program for a pharmaceutical manufacturer to provide financial assistance to certain patients,...more
1/8/2021
/ Advisory Opinions ,
Anti-Kickback Statute ,
Financial Assistance Policies ,
Food and Drug Administration (FDA) ,
Home Health Agencies ,
Manufacturers ,
Medicare ,
OIG ,
Pharmaceutical Industry ,
Prescription Drugs ,
Preventive Health Care ,
REMS ,
Skilled Nursing Facility
On July 10, 2019, Judge Rudolph Contreras of the U.S. District Court for the District of Columbia granted HHS’ request for a final judgment, clearing the way for the government to immediately appeal his earlier decision that...more
7/22/2019
/ American Hospital Association ,
Appeals ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Final Rules ,
Hospitals ,
Jurisdiction ,
Medicare ,
Outpatient Prospective Payment System (OPPS) ,
Prescription Drug Coverage ,
Prescription Drugs ,
Section 340B ,
Ultra Vires